About Artelon
Artelon is a company based in Marietta (United States) founded in 1986 by Lars Peterson was acquired by Stryker in June 2024. Artelon has raised $20 million across 1 funding round from investors including Stryker and Vensana Capital. Artelon offers products and services including FLEXBAND. Artelon operates in a competitive market with competitors including Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
- Headquarter Marietta, United States
- Founders Lars Peterson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Artelon
Artelon offers a comprehensive portfolio of products and services, including FLEXBAND.
Enhances strength of repaired tissues for ankle stability.
People of Artelon
Unlock access to complete
Funding Insights of Artelon
Artelon has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series B round of $20 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Artelon
Artelon has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker and Vensana Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in medical technology are made by Vensana Capital.
|
Locked | Locked | Locked | |
|
3D-printed orthopedic products are manufactured for medical applications.
|
Locked | Locked | Locked |
Investor details for Artelon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Artelon
Investment portfolio details for Artelon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Artelon
Detailed financials for Artelon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Artelon Comparisons
Peer comparison for Artelon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Artelon
Artelon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Aziyo Biologics, MiMedx Group, Ossio and RevBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
Detailed competitors of Artelon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Artelon
Complete news archive for Artelon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Artelon
Artelon was founded in 1986 and raised its 1st funding round 37 years after it was founded.
Artelon is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.
Aaron Smith is the current CEO of Artelon.
Artelon is a funded company, having raised a total of $20M across 1 funding round to date.
Artelon was founded in 1986 and is headquartered in Marietta, United States. Biomaterials are developed by the company for regenerative medicine, targeting soft tissue reconstruction in tendons and ligaments. Solutions are provided for pain management, functional restoration, arthritis treatment, and deformity correction. Elasticity is enhanced in healing tissues to support natural motion, within the medical devices and biotechnology sector.
Artelon's top competitors include EpiBone, Theradaptive and MiMedx Group.
Artelon offers FLEXBAND.
Artelon has 2 investors. Key investors include Stryker, and Vensana Capital.